Biosafety & Containment
• An unprecedented new layer of protection for people processing cells
• No dependence on HVAC or brick-and-mortar
CELL THERAPY MANUFACTURING BIOHAZARDS
• Cells from diseased patients (HIV, hepatitis, ebola, prion, TB, MRSA, etc.).
• Virus and vectors in genetic engineered cells.
• Off-target gene edited cells.
Quality recognizes that all personnel must be fully protected from cells harboring virus, vectors, prions, and other infectious pathogens by 100% separation and 100% containment of spills, splashes, and aerosols. Looming bio-safety concerns and associated liability must be addressed without having to depend on specialized brick-and-mortar biosafety facilities, including unclassified clinical settings. The Cytocentric X2 Platform does this now.
CYTOCENTRIC MODULAR CLOSED ASEPTIC CONTAINMENT ISOLATOR
Xvivo System model 2 is safer than P3 facility.
FITS ANY FACILITY
• Independent of HVAC. Independent of room pressures.
• All gases supplied from controlled remote source (tanks or generators).
• All exhaust removed to controlled remote destination via vacuum.
• No use of room air. No intermixing with room air. No release into room.
CONTAINMENT ELIMINATES RISK OF CROSS CONTAMINATION
• Independent of HVAC. Independent of room pressures.
• All gases supplied from controlled remote source (tanks or generators).
• All exhaust removed to controlled remote destination via vacuum.
• No use of room air. No intermixing with room air. No release into room.